ESR1 and breast cancer: Recently, however, it was reported that dietary administration of δ- and γ-TP inhibited tumorigenesis in an animal model of estrogen receptor (ER)-positive but not human epidermal growth factor receptor (HER-2)-positive breast cancer (18).